Skip to main content
. 2022 May 12;198(8):735–743. doi: 10.1007/s00066-022-01953-y

Fig. 3.

Fig. 3

Kaplan–Meier curves for metastasis-free survival for external beam radiation therapy (EBRT, red line) versus external beam radiation therapy + high-dose-rate brachytherapy boost (EBRT+HDR-BT, blue line) after propensity score matching, with corresponding 95% confidence intervals